The historical data on prostate malignant neoplasms mortality in Mexico, represented in thousands of male deaths, reveals notable trends. In 2023, the mortality rate stood at 7.96 thousand. Over the past decade, the year-on-year variation showed significant fluctuations with a particularly high growth in 2020 at 16.82%, possibly attributable to external factors. The recent years’ trends (2021-2023) show a more modest increase of 2.98% in 2022 and 2.87% in 2023. The compound annual growth rate (CAGR) over the last five years is calculated at 3.88%.
Forecasts reveal a steady increase with a future 5-year CAGR forecast at 2.01%, indicating a growth rate of approximately 10.47% by 2028. The anticipated increase in mortality rates aligns with previous trends but at a slightly moderated pace.
Future trends to watch for:
- The impact of healthcare improvements and new medical interventions on mortality rates.
- Potential demographic changes such as aging populations.
- The influence of public health initiatives and awareness campaigns on early detection and treatment outcomes.
